Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine added to dexmedetomidine and propofol for pediatric upper gastrointestinal endoscopy sedation
IRCT20180416039326N21Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketamine, dexmedetomidine and propofol in None (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Depth of relaxation, Blood pressure and 6 more. Started May 2022; status: completed.
02
Drugs
ketaminedexmedetomidinepropofol
Beyond the preview
Go deeper on IRCT20180416039326N21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180416039326N21.